Dermatology Times, July 2019 (Vol. 40, No. 7)

For many dermatologists, the idea of starting a practice may seem daunting. Learn from Terrence Keaney, M.D., FAAD, as he offers five things he's learned from opening his practice in 2017.

Read about the recent advancements in noninvasive imaging modalities that are making an impact on dermatological care. 

Laser-assisted drug delivery used to fractionally ablate the target area prior to topical medical treatment can be useful in patients with widespread actinic damage, says this expert.

Dermatologists should work to gain a better understanding of immunologic pathways as well as the mechanisms of new and evolving immunotherapies, as these are key for understanding many current and emerging melanoma treatments, one expert says.

Sunscreen has been in the news as a recent study found that active ingredients in commercially available sunscreens quickly enter the bloodstream at levels far exceeding the recommended threshold. Still, researchers and physicians are urging Americans to continue using sunscreen, until more is known. These experts explain why.

Some chemicals in over-the-counter sunscreens may impair marine life, says the National Ocean Service. As a result, they are recommending people choose sunscreens without these chemicals ingredients.

When it comes to easily-recognized, benign, self-limited conditions like warts and molluscum, Dr. Siegfried calls herself a treatment nihilist. Learn why in this article.

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

As Dermatology Times celebrates 40 years of continuous publication, we asked Dr. Levine to share his thoughts on his years of contribution to the publication.

To celebrate the 40th Anniversary of Dermatology Times, we asked our Editorial Advisory Board members to reflect on the publication and how the practice of dermatology has changed over the past 40 years. In this article, Dr. Wheeland reviews his years of involvement with the Dermatology Times and what has happened in the dermatologic surgery world over those same years.

Pulsed dye laser (PDL) is widely accepted as the gold standard treatment of port-wine stains (PWS), but how early can you begin treating infants with PWS? According to this expert and a recent study, the sooner the better. 

The Food, Drug and Cosmetic Act (FDCA) gives the U.S. Food and Drug Administration (FDA) the authority to ensure that drug/device promotion is not false and/or misleading. But does that mean the FDA can regulate physician comments on drugs and devices? Dr. Goldberg provides his insight in this month's Legal Eagle column.

This article is the first of our series on psychodermatology from Gina M. Caputo, D.O. In it, she highlights the prevalence of emotional disorders in patients with skin diseases, and introduces the four main classifications of psychodermatological disorders.

New drugs in clinical trials for the treatment of warts and molluscum contagiosum could improve on currently available therapies, which are limited, used off-label and often cause tissue damage.

In this Medical News Minute, Dr. Bobby Lazzara discusses the specifics regarding injection site reactions.

Although skin aging is largely a result of genetics and UV exposure, menopause also plays a significant role.

Are you training your patients on how to use their self-injectable medications safely and effectively? If not, you may want to start, according to researchers of a recent study, which examined patient behavior surrounding self-injection devices.

Marketing expert Justin Knott explains how to make your Google business profile part of a successful digital marketing strategy.

‘Inflammaging’ is real, says one expert, and can result from chronic inflammation, cell senescence and other internal processes.

From skin care to skin cancer, treating patients of all ages and throughout life stages creates patient loyalty and fosters aesthetic leadership.

Psoriasis patients with skin of color experience psoriasis differently, often reporting worse health related quality of life outcomes compared to their Caucasian peers. Brodalumab may help, suggests a recent study.

Study suggests rosacea may be outcome of systemic inflammation with evidence linking the condition to cardiovascular disease, inflammatory bowel disease, and even some neurological diseases.

Continued research has led to a variety of melanoma immunotherapy medications, leading to improved survival of melanoma patients. Clinicians should have a firm grasp of the immune mechanisms behind these novel therapies to provide the best advice on treatment and management options of their melanoma patients